USP-Compliant Analysis of Antibody Drugs Using Size-Exclusion Chromatography (SEC)

Applications | 2024 | ShimadzuInstrumentation
GPC/SEC
Industries
Pharma & Biopharma
Manufacturer
Shimadzu
Downloadable PDF for viewing
 

Similar PDF

Evaluation of Modern and Legacy HPLC Systems for the Size-Exclusion Analysis of Aggregation and Fragmentation in a Monoclonal Antibody Drug
Impact of LC System Dispersion on the Size-Exclusion Chromatography Analysis of Monoclonal IgG Antibody Aggregates and Fragments:  Selecting the Optimal Column for Your Method
SIZE-EXCLUSION CHROMATOGRAPHY (SEC) OF PEPTIDES, PROTEINS, AND AAVs
Agilent Biocolumns - Aggregate/Fragment Analysis - Application Compendium